10.6084/m9.figshare.5797572.v1 Tian-li Xia Tian-li Xia Fang-yang Huang Fang-yang Huang Yi-ming Li Yi-ming Li Hua Chai Hua Chai Bao-tao Huang Bao-tao Huang Yuan-Wei-Xiang Ou Yuan-Wei-Xiang Ou Qiao Li Qiao Li Xiao-bo Pu Xiao-bo Pu Zhi-liang Zuo Zhi-liang Zuo Yong Peng Yong Peng Mao Chen Mao Chen De-jia Huang De-jia Huang Additional file 4: of The impact of age on the implementation of evidence-based medications in patients with coronary artery disease and its prognostic significance: a retrospective cohort study Springer Nature 2018 Coronary artery disease Elderly Evidence-based medications Mortality 2018-01-17 05:00:00 Journal contribution https://springernature.figshare.com/articles/journal_contribution/Additional_file_4_of_The_impact_of_age_on_the_implementation_of_evidence-based_medications_in_patients_with_coronary_artery_disease_and_its_prognostic_significance_a_retrospective_cohort_study/5797572 Multivariate Cox’s proportional hazards regression model on combination therapy of EBMs. Adjusted factor: sex, history of hypertension, history of diabetes mellitus, and history of heart failure, history of dyslipidemia, smoking status, eGFR and hepatic enzymes. Model 0: no medication; model 1: prescribed 1 type of EBMs; model 2, prescribed 2 types of EBMs; model 3, prescribed all 3 types of EBMs. Three types of EBMs included: statin, beta-blockers, and RAAS inhibitors (ACEIs or ARBs). Abbreviations: EBMs: evidence-based medications, CAD: coronary artery disease, CI: confidence interval, CV death: cardiovascular death, HR: hazard ratio. (DOCX 13 kb)